AMS71 That is interesting. I'm assuming that your chart is showing an off market trade.
With recent announcements confirming the commencement of 2 of the 1b/2 patient dosing trials in both the Ovarian and AML trials I can understand a holder taking a solid position but a I have some trouble understanding the sellers mind set.
This space is going to get very interesting.
Ann: First Patient Dosed on Phase 1b/2 AML Trial, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
